The idea of stem cells is quite interesting, seeing as how these particular cells have the ability to generate new cells when active. This is an especially important point in the field of brain cancer research, as it seems like the same can be said for cancer stem cells. On the surface, this idea is practically ideal for there to be new therapies conducted down the road. Fortunately, this appears to be the case, if a recent study on the matter is anything to go by.
Science Daily posted an article about a study that was done with the focus being on stem cells. It was done through a group of people from the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery and what was found were a group of immune system targets resting upon cancer stem cells. In response, an experimental vaccine was designed for the purpose of targeting them. This drug stands the chance of being great in this field, especially if the research that has been done proves itself as worthwhile.
The research was done and what was picked up on, in particular, was a protein by the name of CD133. The experiment was done with mice, the aforementioned vaccine being put into place for the sake of determining if an immune response would follow. When it comes to the positives of this study, it was shown that this vaccine could be implemented without damaging the healthy cells or organs. The ability to minimize damage should be the focus of surgery in general, regardless of the brain being targeted or not.
Those who have invested ample time in brain cancer research can tell you that there is a tremendous amount of importance that comes with the CD133 protein. Seeing as how this particular protein has been linked to the resistance of cancer stem cells to treatment options, it is perhaps the ideal target for immunotherapy. While it's unknown if this procedure can prevent tumors from returning once they are removed, efforts are being made to find out more information. Organizations like Voices against Brain Cancer should make note of this.
It's apparent that stem cells have been a part of medicine in the past and they've been given such great focus as a result. It's clear that these cells have had a number of claims associated with them, such as the thought of humans re-growing body parts that have been lost. Regardless, these cells have been given a tremendous amount of focus and the same can now be said about brain cancer research. With such a broad field to focus on, it may not be long until greater results in this field are seen.
Science Daily posted an article about a study that was done with the focus being on stem cells. It was done through a group of people from the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery and what was found were a group of immune system targets resting upon cancer stem cells. In response, an experimental vaccine was designed for the purpose of targeting them. This drug stands the chance of being great in this field, especially if the research that has been done proves itself as worthwhile.
The research was done and what was picked up on, in particular, was a protein by the name of CD133. The experiment was done with mice, the aforementioned vaccine being put into place for the sake of determining if an immune response would follow. When it comes to the positives of this study, it was shown that this vaccine could be implemented without damaging the healthy cells or organs. The ability to minimize damage should be the focus of surgery in general, regardless of the brain being targeted or not.
Those who have invested ample time in brain cancer research can tell you that there is a tremendous amount of importance that comes with the CD133 protein. Seeing as how this particular protein has been linked to the resistance of cancer stem cells to treatment options, it is perhaps the ideal target for immunotherapy. While it's unknown if this procedure can prevent tumors from returning once they are removed, efforts are being made to find out more information. Organizations like Voices against Brain Cancer should make note of this.
It's apparent that stem cells have been a part of medicine in the past and they've been given such great focus as a result. It's clear that these cells have had a number of claims associated with them, such as the thought of humans re-growing body parts that have been lost. Regardless, these cells have been given a tremendous amount of focus and the same can now be said about brain cancer research. With such a broad field to focus on, it may not be long until greater results in this field are seen.
About the Author:
If you are interested in absorbing more about brain cancer research, please consult Voices against Brain Cancer.
Aucun commentaire:
Enregistrer un commentaire